home / stock / nicxf / nicxf short
Short Information | Nicox SA (OTCMKTS:NICXF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 26,971 |
Total Actual Volume | 35,726 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 17 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 1,349 |
Average Short Percentage | 83.05% |
Is there a NICXF Short Squeeze or Breakout about to happen?
See the NICXF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-17-2023 | $0.6362 | $0.6362 | $0.6362 | $0.6362 | 1,000 | 1,000 | 100% |
06-01-2021 | $5.1 | $5.1 | $5.1 | $5.1 | 300 | 300 | 100% |
04-14-2021 | $5.12 | $5.15 | $5.15 | $5.12 | 3,600 | 1,600 | 44.44% |
02-25-2021 | $5.48 | $5.54 | $5.54 | $5.48 | 300 | 200 | 66.67% |
02-17-2021 | $5.5 | $5.5 | $5.5 | $5.5 | 100 | 100 | 100% |
01-06-2021 | $5.43 | $5.43 | $5.43 | $5.43 | 100 | 100 | 100% |
11-30-2020 | $6.44 | $6.46 | $6.46 | $6.44 | 200 | 100 | 50% |
11-17-2020 | $5.08 | $5.08 | $5.08 | $5.08 | 2,000 | 2,000 | 100% |
04-13-2020 | $4.28 | $4.23 | $4.28 | $4.23 | 3,000 | 900 | 30% |
02-03-2020 | $4.985 | $4.985 | $4.985 | $4.985 | 100 | 100 | 100% |
12-12-2019 | $4.37 | $4.24 | $4.37 | $4.24 | 6,200 | 6,000 | 96.77% |
12-09-2019 | $4.25 | $4.25 | $4.25 | $4.25 | 4,500 | 2,000 | 44.44% |
12-06-2019 | $4.30 | $4.13 | $4.30 | $4.13 | 7,304 | 5,897 | 80.74% |
10-22-2019 | $5.51 | $5.51 | $5.51 | $5.51 | 1,200 | 1,200 | 100% |
10-02-2019 | $5.85 | $5.91 | $5.91 | $5.755 | 3,965 | 3,800 | 95.84% |
09-17-2019 | $5.84 | $5.84 | $5.84 | $5.84 | 575 | 494 | 85.91% |
08-16-2019 | $4.96 | $4.96 | $4.96 | $4.96 | 100 | 100 | 100% |
08-02-2019 | $5.06 | $5.06 | $5.06 | $5.06 | 302 | 200 | 66.23% |
07-11-2019 | $5.50 | $5.50 | $5.50 | $5.50 | 500 | 500 | 100% |
06-21-2019 | $5.62 | $5.62 | $5.62 | $5.62 | 380 | 380 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Nicox SA Company Name:
NICXF Stock Symbol:
OTCMKTS Market:
Attachment EN_DenaliLastUSPatient_PR_FINAL
Attachment EN_Nicox Conferences 2024_FINAL
1 Net revenue consists of revenue from collaborations less royalty payments 2 Intra-ocular pressure Attachment EN_Q22024Results_PR_FINAL